Hemodynamic imbalance in ST elevation myocardial infarction

V.V. Hemradj

Hemodynamic imbalance in ST elevation myocardial infarction

Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Abstract

During the last decades, prognosis of myocardial infarction has improved. However, if myocardial infarction is complicated by cardiogenic shock, early mortality is still unacceptably high, approximately 50%. Current treatment include vasopressor or inotropic pharmacological therapy or hemodynamic circulatory support. The most commonly used percutaneous circulatory support

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	University of Amsterdam
Supervisors/Advisors	Simao Henriques, Jose, Supervisor Ottervanger, Jan Paul, Co-supervisor, External person
Award date	16 Nov 2023
Print ISBNs	9789463619318
Publication status	Published - 2023

Access to Document

Cite this

@phdthesis{9777a513f6534314a31943d8197404f5,

title = "Hemodynamic imbalance in ST elevation myocardial infarction",

abstract = "During the last decades, prognosis of myocardial infarction has improved. However, if myocardial infarction is complicated by cardiogenic shock, early mortality is still unacceptably high, approximately 50%. Current treatment include vasopressor or inotropic pharmacological therapy or hemodynamic circulatory support. The most commonly used percutaneous circulatory support",

author = "V.V. Hemradj",

year = "2023",

language = "English",

isbn = "9789463619318",

type = "Phd-Thesis - Research and graduation internal",

school = "University of Amsterdam",

}

TY - THES

T1 - Hemodynamic imbalance in ST elevation myocardial infarction

AU - Hemradj, V.V.

PY - 2023

Y1 - 2023

N2 - During the last decades, prognosis of myocardial infarction has improved. However, if myocardial infarction is complicated by cardiogenic shock, early mortality is still unacceptably high, approximately 50%. Current treatment include vasopressor or inotropic pharmacological therapy or hemodynamic circulatory support. The most commonly used percutaneous circulatory support

AB - During the last decades, prognosis of myocardial infarction has improved. However, if myocardial infarction is complicated by cardiogenic shock, early mortality is still unacceptably high, approximately 50%. Current treatment include vasopressor or inotropic pharmacological therapy or hemodynamic circulatory support. The most commonly used percutaneous circulatory support

UR - https://pure.uva.nl/ws/files/144609096/Licentieovereenkomst_medeondertekend_.pdf

UR - https://pure.uva.nl/ws/files/144609098/Overzicht_van_de_verschillen.docx

M3 - Phd-Thesis - Research and graduation internal

SN - 9789463619318

ER -

Hemodynamic imbalance in ST elevation myocardial infarction

Abstract

Access to Document

Other files and links

Cite this